NFKB1 and polycystic ovary syndrome: An interventional study investigating anti-inflammatory treatment with the NFκB inhibitor salsalate in eight women with PCOS demonstrated improvement in ovarian steroid metabolism and suggested positive effects on ovulatory function (24).